BankPlus Trust Department’s abrdn Life Sciences Investors HQL Stock Holding History

BankPlus Trust Department’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,134	Closed	-$42.7K	–	295
2026 Q2	$42.7K	Hold	2,134	–	–	0.01%	285
2026 Q1	$34.7K	Hold	2,134	–	–	0.01%	294
2025 Q4	$35.8K	Hold	2,134	–	–	0.01%	280
2025 Q3	$33.1K	Hold	2,134	–	–	0.01%	280
2025 Q2	$27.3K	Hold	2,134	–	–	0.01%	283
2025 Q1	$27.1K	Hold	2,134	–	–	0.01%	281
2024 Q4	$28K	Buy	+2,134	New	+$30.8K	0.01%	273

Other funds holding HQL

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Formidable Asset Management Cincinnati, Ohio $680M AUM 8.59% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.34B AUM 22.84% 1-Year Est. Return

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $840M AUM 13.7% 1-Year Est. Return

UHLMANN PRICE SECURITIES Skokie, Illinois $1.86B AUM 66.72% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

BankPlus Trust Department's HQL Position: Q3 2026 in Review

BankPlus Trust Department sold out of abrdn Life Sciences Investors (HQL) in Q3 2026, closing a stake of 2,134 shares — an estimated $42.7K sold.

BankPlus Trust Department first reported a position in HQL in Q4 2024 and held it in 7 quarters. The position peaked at $42.7K in Q2 2026. 58 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

BankPlus Trust Department reported no remaining abrdn Life Sciences Investors position as of Q3 2026 after selling out during the quarter.
BankPlus Trust Department sold 2,134 abrdn Life Sciences Investors shares in Q3 2026, an estimated $42.7K.
BankPlus Trust Department first reported a position in abrdn Life Sciences Investors in Q4 2024 and held it in 7 quarters.
BankPlus Trust Department's abrdn Life Sciences Investors position peaked at $42.7K in Q2 2026.
58 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on BankPlus Trust Department's 13F filing for Q3 2026, filed 6 Nov 2026.